Bioaffinity Technologies Inc.

13F holders, Q1 2025 (March 31)
17holders +1
4new positions
3sold out
$0.26avg. 13F price*

At the end of Q1 2025, 17 institutions reported holding Bioaffinity Technologies Inc. in their 13F filings, up 1 from Q4 2024. 4 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($46K), Geode Capital Management, LLC ($31K) and Sheaff Brock Investment Advisors, LLC ($14K).

Company
Bioaffinity Technologies Inc.
CUSIP
09076W109
Latest filing quarter
Q3 2025

History

Number of 13F holders

05101520 Q1 2024: 14Q1 2024Q2 2024: 17Q2 2024Q3 2024: 14Q3 2024Q4 2024: 16Q4 2024Q1 2025: 17Q1 2025Q2 2025: 17Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions4$15K
Exits3$28K

All 13F filers, Q4 2024 → Q1 2025: 94,098 shares bought and 117,498 shares sold, net −23,400 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 17 holders

Vanguard Group Inc. 0.00% Reduce -32.2% 176,897 $46K
Geode Capital Management, LLC 0.00% Add +19.2% 118,689 $31K
Sheaff Brock Investment Advisors, LLC 0.00% Add +16.1% 53,734 $14K
Captrust Financial Advisors 0.00% No change 27,885 $7K
Warberg Asset Management LLC 0.02% New 22,500 $6K
State Street Corp. 0.00% No change 17,600 $5K
Van Hulzen Asset Management, LLC 0.00% New 16,012 $4K
HRT Financial LP 0.00% New 18,841 $4K
IFP Advisors, Inc 0.00% Add +50.0% 15,000 $4K
Northern Trust Corp. 0.00% No change 13,662 $4K
XTX Topco Ltd 0.00% Add +18.8% 12,608 $3K
Creative Planning 0.00% No change 12,095 $3K
Barclays PLC 0.00% New 3,181 $827
Tower Research Capital LLC (TRC) 0.00% Reduce -50.4% 3,141 $817
Morgan Stanley 0.00% Reduce -40.0% 300 $78
Bank of America Corp. 0.00% Add +4.8% 88 $23
JPMorgan Chase & Co. 0.00% Reduce -14.3% 18 $5

"% of holder's portfolio" is BIOAFFINITY TECHNOLOGIES INC's weight in each manager's 13F, not the share of Bioaffinity Technologies Inc. the manager owns.